(+)-Posiphen Uses, Dosage, Side Effects and more
(+)-Posiphen is under investigation in clinical trial NCT02925650 (Safety, Tolerability, PK and PD of (+)-Posiphen® in Subjects With Early Alzheimer's Disease).
| Attribute | Details |
|---|---|
| Trade Name | (+)-Posiphen |
| Generic | Posiphen |
| Posiphen Other Names | (+)-Posiphen |
| Type | |
| Formula | C20H23N3O2 |
| Weight | Average: 337.423 Monoisotopic: 337.179026993 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
